BR
Schedule 13G filing
BlackRock, Inc. cut its KRRO stake below 5%
BlackRock, Inc. reported owning 4.9% of Korro Bio, Inc. (KRRO) (717,813 shares) in a Schedule 13G filed Oct 27, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
More KRRO insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.